A population-based survival analysis of mesothelioma and smoking in Appalachian and Non-Appalachian Kentucky by Van Wie, Peter
University of Kentucky 
UKnowledge 
Theses and Dissertations--Public Health (M.P.H. 
& Dr.P.H.) College of Public Health 
2017 
A population-based survival analysis of mesothelioma and 
smoking in Appalachian and Non-Appalachian Kentucky 
Peter Van Wie 
University of Kentucky, pgva222@g.uky.edu 
Follow this and additional works at: https://uknowledge.uky.edu/cph_etds 
 Part of the Public Health Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Van Wie, Peter, "A population-based survival analysis of mesothelioma and smoking in Appalachian and 
Non-Appalachian Kentucky" (2017). Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.). 159. 
https://uknowledge.uky.edu/cph_etds/159 
This Graduate Capstone Project is brought to you for free and open access by the College of Public Health at 
UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.) by an 
authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my capstone and abstract are my original work. Proper attribution has been 
given to all outside sources. I understand that I am solely responsible for obtaining any needed 
copyright permissions. I have obtained needed written permission statement(s) from the 
owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic 
distribution (if such use is not permitted by the fair use doctrine) which will be submitted to 
UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s capstone including 
all changes required by the advisory committee. The undersigned agree to abide by the 
statements above. 
Peter Van Wie, Student 
Wayne Sanderson, PhD, MS, Committee Chair 




A population-based survival analysis of mesothelioma and smoking in 
Appalachian and Non-Appalachian Kentucky 
 
 
Capstone Project Paper 
 
A paper submitted in partial fulfillment of the requirements 
for the degree of Maters of Public Health 
In the University of Kentucky College of Public Health 
 
By Peter Van Wie 
Lexington Kentucky 









Dr. Wayne Sanderson, PhD, MS, Chair 
____________________________________________ 
Dr. David Mannino, MD, Committee Member 
____________________________________________ 




Table of Contents 
Abstract ............................................................................................................... 3 
Introduction ......................................................................................................... 4 
Material and Methods ......................................................................................... 8 
Results ............................................................................................................... 10 
Table 1: Demographics of Appalachian and Non-Appalachian 
Populations .................................................................................................... 10 
Table 2: All Cause Unadjusted and Adjusted Survival Analysis of 
Mesothelioma Diagnoses from 1995 to 2011 as reported by the Kentucky 
Cancer Registry ............................................................................................. 11 
Table 3: Adjusted Analysis by Stage at Diagnosis among those 
Diagnosed with Mesothelioma from 1995 to 2011 as Reported by the 
Kentucky Cancer Registry ............................................................................ 13 
Discussion ......................................................................................................... 15 
Biographical Sketch ......................................................................................... 18 
BIOGRAPHICAL SKETCH .......................................................................... 18 
A. Personal Statement ................................................................................. 18 
B. Positions and Honors .............................................................................. 18 
Positions and Employment .......................................................................... 18 
Other Experience and Professional Memberships ....................................... 18 
Honors ......................................................................................................... 19 
D. Additional Information: Research Support and/or Scholastic Performance
 ..................................................................................................................... 19 
Completed Research Support ...................................................................... 19 





Mesothelioma is one of the most aggressive cancers in the United States 
and around the world, with a grim 5-year survival rate of only 8%. After diagnosis 
there is little that can be done to stop the progression of the disease. Smoking 
has been negatively associated with mesothelioma survival. This may be due to 
several factors including increased oxidative stress or sequestration of tobacco-
related carcinogenic compounds by asbestos fibers trapped in the lung. This 
study investigated the association between smoking and mesothelioma survival 
in the Kentucky population. It examines the risk of living in the low socioeconomic 
region of Appalachian Kentucky. This study is a population-based study that 
included those diagnosed with mesothelioma as reported by the Kentucky 
Cancer Registry (KCR) between 1995 and 2011. The KCR is a Surveillance, 
Epidemiology, and End Results (SEER) organization that has maintained gold 
standard certification since it was founded. Stage at diagnosis was significantly 
associated with survival rate. Cox proportional hazard multivariable model 
describing mesothelioma survival from all deaths was separated by stage: early, 
late, and unknown. Smoking was strongly associated with late stage 
mesothelioma diagnosis with a HR of 1.528 (p = 0.0057). However there was no 
significant difference in survival between Appalachian and non-Appalachian 
residents. This study suggests that cigarette smoke exposure may decrease 






Mesothelioma is one of the most aggressive cancers in the United States 
and around the world, with a grim 5-year survival rate of only 8%. Mesothelioma 
has a long latency period around 30-45 years [2, 3]. After diagnosis there are few 
things that can be done to stop the spread of the disease. There are several 
treatments that have been known to slow or stop the progression of the disease 
after diagnosis; the standard treatments are surgery, radiation, and 
chemotherapy.  Likewise there are a few lifestyle choices or environmental 
exposures that can change the progression of the disease. For example, 
smoking, and low socioeconomic status have been negatively associated with 
mesothelioma survival, while eating healthy, getting exercise, and having access 
to healthcare has been positively associated with mesothelioma survival [4, 5]. 
The 20th century has seen an increase in mesothelioma incidence [6]. 
Asbestos is the primary known cause of mesothelioma, though there are 
still cases that appear with unknown reasons [7]. Many cases of mesothelioma 
are related to occupational exposure. In the 1970s asbestos was banned from 
many household and industrial uses [8]. Though the ban is still in place, the 
incidence rate of the disease remains high. Asbestos is still present in many, 
buildings, ships, piping, automotive and household products [9, 10]. Asbestos 
has also been discovered in newly manufactured products imported from abroad 
where there are looser regulations on the use of asbestos. The continued use of 
asbestos makes mesothelioma an ongoing concern. 
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Mesothelioma is a cancer that permeates the mesothelium, which lines 
the lungs and chest cavity. The peritoneum may also be affected but the majority 
of cases affect the pleural lining of the 
lungs. There are three major 
hypotheses for the mechanism of 
disease reviewed by Toyokuni in 2009 
[1]. The major hypotheses are 
oxidative stress, chromosome 
tangling, and the absorption of 
carcinogenic agents. 
There are two mechanisms 
linking asbestos to oxidative stress. 
First, asbestos can contain iron, or 
possibly sequester iron that can 
catalyze Fenton’s reaction H2O2  OH. Second, when macrophages engulf 
asbestos, the particles can puncture the walls of the macrophages causing them 
to leak reactive oxygen and other digestive enzymes. For these reasons, 
asbestos is thought to produce reactive oxygen species (ROS) [1].  
The second hypothesis, chromosome tangling, suggests that asbestos 
fibers facilitate the rearrangement of chromosomes during replication. 
Chromosome 22 is particularly noted as a hotspot for mutation in mesothelioma. 
Chromosomes 1, 3, 6, and 9 are also commonly mutated in mesothelioma [11]. 
Several studies found the tumor suppressor gene p16 on chromosome 9 
Figure 1. This figure outlines three common 
hypotheses for the mechanism of asbestos-induced 
mesothelioma [1]. 
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(involved in cell cycle regulation by inhibiting CDKs) was absent in most 
mesothelioma cases. The absence of p16 is associated with worse clinical 
outcome [12, 13]. 
A third mechanism of disease commonly hypothesized is that of 
adsorption. Asbestos may sequester harmful chemicals for example those found 
in cigarettes, or may generate a film of proteins or surfactant. This can cause 
harm directly or may attract macrophages and neutrophils to the site, increasing 
inflammation and worsening prognosis [1]. There are many harmful chemicals in 
tobacco smoke that cause or contribute to lung inflammation and cancer. There 
are over 70 known carcinogens in cigarette smoke [14]. Some harmful 
constituents include nicotine, which has been observed to increase cell 
proliferation, inhibit apoptosis, and increase angiogenesis [15-17]. Acrolein, 
acetaldehyde, and formaldehyde are reactive aldehydes that can generate ROS 
contributing to oxidative stress [18]. Polyaromatic hydrocarbons can be 
metabolized by CYP1A1 or CYP1B1 to reactive intermediates that can cause 
DNA damage [19]. Carcinogenic metals like Cd, Ni, Cr, As, and Pb can also be 
found in cigarette smoke. These metals contribute to cancer by generation of 
reactive oxygen species or contributing to Fenton-like reactions [20]. 
Smoking has been negatively associated with mesothelioma survival [21-
23]. This may be due to several factors including increased oxidative stress [24, 
25] or sequestration of tobacco related carcinogenic compounds by asbestos 
fibers trapped in the lung [1]. This study assessed the association between 
smoking and mesothelioma survival in the population of Kentucky. 
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 Socioeconomic status (SES) has been associated with cancer incidence 
and survival [26]. The Appalachian region of Kentucky has 38 distressed 
counties which rank in the worst 10% of the nation’s counties [27]. A study was 
conducted to analyze socioeconomic status and survival of lung cancer. This 
study found that middle-low, middle-high, and highest SES were positively 
associated with survival compared with lowest SES with hazard ratios (HR) of 
0.96 (95% CI 0.94-.99) 0.92 (95% CI 0.89-0.94) and 0.87 (95% CI 0.84-0.91) 
respectively [28]. Poor socioeconomic status has been associated with reduced 
mesothelioma survival [4]. For these reasons, living in Appalachian Kentucky 
was analyzed as a risk factor for mesothelioma survival in Kentucky. 
Kentucky is the state with the highest rate of lung cancer, and is in the top 
ten for mesothelioma [29]. The incidence rates of mesothelioma have not 
returned to their former levels even after the ban on the use of asbestos. 
Smoking is also very common in Kentucky and is thought to increase risk for the 
development of mesothelioma [30]. Smoking was identified to negatively impact 
survival in lung cancer. One study found a hazard ratio (HR) of 1.38 (95% CI, 
1.19-1.60) after adjusting for comorbidities and covariates [31]. Another study 
looking at lung function and survival found smoking to be negatively associated 
with survival with a HR of 2.29 (95% CI, 1.23-4.26) [22].  
This study is a population-based study that associates smoking and 
abiding in Appalachian Kentucky with the survival of pleural mesothelioma 
patients. There have been previous studies on mesothelioma survival, but this 
study is different in that it focuses on the risk of smoking and the progression of 
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the disease in a population that is at high risk. Kentucky has the highest rate of 
smoking related deaths, the highest smoking rate of those in high school, and is 
the nation’s second highest for adult smokers [32].  
Material and Methods 
This study is a population-based study that includes those diagnosed with 
mesothelioma as reported by the Kentucky Cancer Registry (KCR). The KCR is a 
Surveillance, Epidemiology, and End Results (SEER) organization that has 
maintained gold standard certification since it was founded. The KCR operates in 
Kentucky with its headquarters in Lexington, KY. The data was collected and de-
identified by the KCR. IRB exempt status was granted for this study. 
 The KCR reports information gathered from medical records. The 
information collected was sufficient for this study. Information included: smoking 
status, geographical location, sex, treatment, histology, health insurance, cause 
of death, menopause, age, marital status, grade of tumor, stage, and race. 
Subjects were followed until death or considered still alive as of May 28, 2013, 
which was the last day of follow up in this dataset. Cases diagnosed in Kentucky 
from 1998-2011 were used for the study. 
 The variables used in this study were categorized as follows. Smoking 
was categorized as smoker, non-smoker, and unknown status. Location was 
described as Appalachian resident, non-Appalachian resident, or unknown. The 
Appalachian region in Kentucky is comprised of 54 counties in eastern Kentucky. 
The majority of counties in Appalachian Kentucky are distressed having at least 
double the national unemployment rate [27]. Age was analyzed as a continuous 
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variable. Stage indicated the metastatic progression of the cancer, and was 
classified as local, regional, distant, or unknown. Histology described the tissue 
affected as epithelial, fibrous, biphasic or unclassified mesothelioma. Healthcare 
variables were private insurance, Medicare, Medicaid, uninsured, or unknown. 
Female was used as the reference group for gender. Treatments included 
surgery, chemotherapy, radiation, or no treatment given by a physician. Marriage 
was coded as married (including common law), unmarried, or unknown. Race 
was not included as a variable because there were too few black cases; there 
were a total of 11 black cases. The final model adjusted variables include: marital 
status, insurance, Appalachian, site, treatment, stage, and age. These 
adjustments were decided beforehand to reduce variability and possible bias in 
comparisons. 
All analyses were conducted using SAS 9.3. Kaplan-Meier curves were 
generated to show the survival rates and Cox regression analyses were 
performed for the hazard analysis. The data was analyzed unadjusted and 
adjusted for age, stage, treatment, site, marriage, and insurance type. The 
information was separated into stages as well because stage at diagnosis played 





From the incidence demographics in table one several observations can 
be made. First mesothelioma appears to mostly affect white males. Smokers 
have a much higher percent distribution than non-smokers. Mesothelioma is 
normally discovered later in life, and the majority of cases are metastatic with 
distant colony formation. Finally, there are several common treatment options, 
chemotherapy being the most commonly administered. Table one provides the 
basic details of the study population and shows differences between Appalachian 
and non-Appalachian residents. 
Table 1: Demographics of Appalachian and Non-Appalachian Populations 




Population at Risk 
N % N % N % 
 434 100 119 27.4 315 72.6 
Age       
20-49 38 8.8 12 10.1 26 8.3 
50-64 103 23.7 32 26.9 71 22.5 
65-74 139 32 37 31.1 102 32.4 
75+ 154 35.5 38 31.9 116 36.8 
Average Age 68.6 years      
Sex       
Male 322 74.2 88 74.0 234 74.3 
Female 112 25.8 31 26.1 81 25.7 
Race       
White/other 423 97.5 118 99.2 305 96.8 
Black 11 2.5 1 0.8 10 3.2 
Smoking       
Non-smoker 113 26 21 17.7 92 29.2 
Smoker 258 59.5 78 65.6 180 57.1 
Unknown 63 14.5 20 16.8 43 13.7 
Insurance       
None 7 1.6 2 1.7 5 1.6 
Private 115 26.5 27 22.7 88 27.9 
Medicaid 14 3.2 7 5.9 7 2.2 
Medicare 287 66.1 77 64.7 210 66.7 
Unknown 11 2.5 6 5.0 5 1.6 
Site       
Unspecified 262 60.4 78 65.6 184 58.4 
Fibrous 34 7.8 10 8.4 24 7.6 
Epithelioid 109 25.1 24 20.2 85 27.0 
Biphasic 29 6.7 7 5.9 22 7.0 
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Stage       
Localized 73 16.8 16 13.5 57 18.1 
Regional 84 19.4 23 19.3 61 19.4 
Distant 197 45.4 56 47.1 141 44.8 
Unknown 80 18.4 24 20.2 56 17.8 
Treatment       
Surgery 109 25.1 34 28.6 75 23.8 
Chemo 169 38.9 43 36.1 126 40.0 
Radiation 67 15.4 17 14.3 50 15.9 
  
 Table two provides unadjusted and adjusted Cox Proportional Hazard 
Ratios (HR) for those who died after mesothelioma diagnosis from all causes. In 
this analysis smoking was significantly linked with poor survival with an adjusted 
HR of 1.448 (95% CI 1.14-1.84). The adjusted HR accounted for marital status, 
insurance, Appalachian, site, treatment, stage, and age. The crude death rate 
was calculated as the number of deaths by all causes divided by the number 
diagnosed multiplied by 100%. The next column shows the five-year survival rate 
post diagnosis. Other factors that played a significant role in survival were age, 
sex, treatment and site. Though there were differences in survival between 
Appalachian and non-Appalachian residents, these observations were not 
statistically significant. 
Table 2: All Cause Unadjusted and Adjusted Survival Analysis of 
Mesothelioma Diagnoses from 1995 to 2011 as reported by the Kentucky 
Cancer Registry 









Adjusted HR (95% 
CI) 
All Cases 434 402 92.6% 0.871   
Age       
Continuous 434 402 92.6% 0.811 1.031 (1.02-1.04) 1.030 (1.02-1.04) 
Sex       
Male 322 309 96.0% 0.864 1.680 (1.33-2.13) 1.494 (1.17-1.90) 
Female 112 93 83.1% 0.658 1 (REF) 1 (REF) 
Smoking       
Non-Smoking 113 102 90.3% 0.738 1 (REF) 1 (REF) 
Smoking 258 243 94.2% 0.842 1.281 (1.02-1.62) 1.448 (1.14-1.84) 
Unknown 63 57 90.5% 0.816 1.274 (0.92-1.76) 1.259 (0.91-1.75) 
Appalachian       
Non-Appalachian 315 294 93.3% 0.817 1 (REF) 1 (REF) 
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Appalachian 119 108 90.8% 0.795 0.998 (0.80-1.25) 1.053 (0.84-1.32) 
Treatment       
Surgery 109 91 83.5% 0.639 1 (REF) 1 (REF) 
Chemo 113 104 92.0% 0.823 1.409 (1.06-1.87) 1.276 (0.96-1.70) 
Radiation 28 28 100% 0.857 1.764 (1.15-2.70) 1.258 (0.80-1.98) 
No Treatment 184 179 97.3% 0.899 2.282 (1.76-2.95) 1.817 (1.37-2.42) 
Site       
Epithelioid 109 96 88.1% 0.729 1 (REF) 1 (REF) 
Fibrous 34 33 97.1% 0.912 1.857 (1.25-2.77) 1.657 (1.10-2.49) 
Biphasic 29 27 93.1% 0.947 2.279 (1.48-3.50) 2.576 (1.67-3.98) 
Unspecified 262 246 93.9% 0.817 1.230 (0.97-1.56) 1.409 (1.10-1.81) 
Insurance       
Private 115 95 82.6% 0.739 1 (REF) 1 (REF) 
Medicaid 14 11 78.6% 0.519 1.088 (0.58-2.04) 1.331 (0.70-2.53) 
Medicare 287 280 97.6% 0.863 1.800 (1.42-2.28) 0.941 (0.68-1.31) 
Not Insured 7 5 71.4% 0.571 0.775 (0.31-1.91) 1.181 (0.48-2.94) 
Unknown 11 11 100% 0.727 1.637 (0.88-3.06) 1.166 (0.59-2.30) 
Marital Status       
Married 188 171 91.0% 0.831 1 (REF) 1 (REF) 
Unmarried 95 88 92.6% 0.787 1.064 (0.82-1.38) 0.868 (0.65-1.12) 
Unknown 151 143 94.7% 0.801 0.968 (0.75-1.21) 1.041 (0.81-1.34) 
*Adjusted for marital status, insurance, Appalachian, site, treatment, stage, and age 
 
 It was important to stratify the data by stage because of the large impact 
stage at diagnosis plays in overall survival. Table 3 shows Cox Proportional 
Hazard multivariable models describing mesothelioma survival from all deaths 
separated by stages: early, late, and unknown. Smoking with a late stage 
mesothelioma diagnosis was negatively associated with survival with a HR of 
1.528 (p = 0.0057). Other pronounced associations in this analysis were no 
treatment having an adjusted HR of 1.986 (p < .0001), and sites fibrous and 
biphasic with adjusted HRs of 2.891 (p < .0001) and 3.153 (p < .0001) 
respectively. However, Appalachian residency remained statistically insignificant 




Table 3: Adjusted Analysis by Stage at Diagnosis among those Diagnosed 




Early Stage N=73 Late Stage N=281 Unknown Stage N=80 












Age       
Continuous  1.032 (0.0389)  1.023 (0.0005)  1.052 (<.0001) 
Sex       
Male .964 1.799 (0.1061) 0.951 1.414 (0.0232) 0.983 1.589 (0.1806) 
Female .824 1 (REF) 0.867 1 (REF) 0.700 1 (REF) 
Smoking       
Non-Smoking 0.722 1 (REF) 0.908 1 (REF) 0.895 1 (REF) 
Smoking 0.932 1.001 (0.9987) 0.941 1.528 (0.0057) 0.956 1.700 (0.0880) 
Unknown 1 1.109 (0.8114) 0.917 1.283 (0.2468) 0.813 1.861 (0.1235) 
Appalachian       
Non-Appalachian 0.930 1 (REF) 0.946 1 (REF) 0.893 1 (REF) 
Appalachian 0.938 1.072 (0.8409) 0.886 1.059 (0.6932) 0.958 0.791 (0.3994) 
Treatment       
Surgery 0.778 1 (REF) 0.971 1 (REF) 0.615 1 (REF) 
Chemo 1 0.901 (0.7952) 0.885 1.275 (0.1589) 0.929 1.454 (0.4607) 
Radiation 1 0.454 (0.2342) 0.900 1.717 (0.0445) 1 1.128 (0.8691) 
No Treatment 0.968 0.926 (0.8532) 0.971 1.986 (<.0001) 0.980 2.311 (0.0548) 
Site       
Epithelioid 1 1 (REF) 0.861 1 (REF) 0.867 1 (REF) 
Fibrous 1 0.221 (0.0249) 0.962 2.891 (<.0001) 1 0.582 (0.4141) 
Biphasic 0.857 1.281 (0.6313) 0.947 3.153 (<.0001) 1 3.000 (0.1166) 
Unspecified 0.913 0.598 (0.1562) 0.955 1.663 (0.0008) 0.915 0.952 (0.8872) 
Insurance       
Private 0.750 1 (REF) 0.859 1 (REF) 0.765 1 (REF) 
Medicaid 1 1.391 0.857 1.812 (0.1761) 0.600 0.955 (0.9472) 
Medicare 1 1.099 0.963 0.871 (0.4855) 1 0.570 (0.2147) 
Not Insured N/A N/A 0.750 1.193 (0.7663) 0.667 0.619 (0.6572) 
Unknown 1 2.632 1 1.573 (0.4617) 1 0.657 (0.4510) 
Marital Status       
Married 0.931 1 (REF) 0.922 1 (REF) 0.636 1 (REF) 
Unmarried 0.943 0.496 (0.0743) 0.943 0.987 (0.9328) 0.818 0.712 (0.5946) 
Unknown 0.914 0.760 (0.3439) 0.931 0.992 (0.9631) 0.983 1.722 (0.2641) 




Smokers and Non-Smokers Survival in Kentucky from 1994-2011 
 
Figure 2. The survival curve for smoking illustrates that smokers had a significantly reduced 
survival rate compared with non-smokers. The difference is most pronounced in the first 50 
months post diagnosis. 
 
Appalachian and Non-Appalachian Survival in Kentucky from 1994-2011 
 




 Through this study smoking can be strongly associated with mesothelioma 
survival. Smoking status had the most dramatic effect on survival for late stage 
patients with a hazard ratio of 1.528 (p = 0.0057). The data indicate that smoking 
is more significantly associated with survival than many other risk factors. These 
findings suggest those who do not smoke will have significantly increased 
survival. Those in high-risk occupations may benefit greatly from smoking 
counseling and cessation programs prior to disease onset. 
 Smoking is both statistically significant and practically significant. The 
study found non-smokers’ survival probability at 24 months is close to 40% while 
smokers’ survival probability is close to 20%. This can be seen in the Kaplan-
Meier curve in Figure 2. This survival probability gap becomes smaller as we 
approach the 5-year mark. Since mesothelioma is a very fast acting cancer once 
diagnosed, both smoking and non-smoking have very low survival probability 
after 5 years. 
Several studies have observed similar hazard ratios when examining 
smoking and lung cancer. In 2003, Tammemagi et al. found a HR of 1.38 
(p>0.001) for smokers compared with non-smokers. Moshammer et al. in 2009 
found an HR of 2.89, while Naomi et al. in 2014 found an HR or 1.39. These 
results support our findings that smoking decreases survival after mesothelioma 
diagnosis. The difference between our study and these studies is that we looked 
at mesothelioma specifically while these other studies reported lung cancers 
generally. Additionally this study is more accurate than previous studies because 
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it analyzes a population while previous studies reported survival ratios based on 
fewer cases. 
Comparing Appalachian Kentucky with non-Appalachian Kentucky did not 
yield any significant change in survival after adjustment for smoking and other 
significant risk factors. The results suggest that there may be little genetic 
predisposition for mesothelioma survival in those who are living in Appalachian 
Kentucky. It indicates that socioeconomic factors in Appalachia may need to be 
better defined rather than analyzing at a county level.  Additionally, it is important 
to note that there are more smokers in Appalachian Kentucky. It still may be 
beneficial to focus smoking cessation programs in this area to extend cancer 
survival. 
 A major strength of this study is that it is a population-based study. The 
data for this study represents all cancer cases from the state of Kentucky from 
1995 to 2011. However, since mesothelioma is a relatively rare disease there 
were only 434 cases during this long time period. For example, there were only 
14 cases holding Medicaid insurance, and only 28 cases received radiation. Most 
other variables had many cases, which increase the predictive power. Smoking 
status was well defined with 113 cases in non-smokers and 258 in smokers. To 
improve some of the lower variables like Medicaid insurance and radiation 
treatment, a national study may be conducted.  
 Some additional information on patients may provide further 
understanding on mesothelioma survival in the future. For example, exercise 
data was not included in this study. People with a history of regular exercise may 
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exhibit a better survival outcome for mesothelioma. It may be helpful in future 
studies to include a short exercise questionnaire as a part of the cancer data 
collection. Exercise has been shown in several studies to reduce cancer risk [33]. 
Additionally, a review showed exercise was correlated with improved survival, but 
smoking was not accounted for in that review [34]. The inclusion of exercise data 
may be a significant addition for mesothelioma survival studies in the future. 
The second additional piece of information that may prove useful in future 
studies is nutritional data. People with a history consuming foods high in 
antioxidants may have higher survival rates. Some studies indicate nutrition plays 
a valuable role in cancer incidence and progression for many different cancer 
types. Foods high in antioxidants have been suggested to lower cancer risk while 
red meats, refined foods, and regular or high alcohol consumption have been 
shown to increase risk [35-37].  
 In conclusion, these data suggest that smoking is a risk factor associated 
with reducing mesothelioma survivability. The data collected from the Kentucky 
Cancer Registry is consistent with reports in the literature for smoking and lung 
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